Kenya marks World TB Day

Kenya marks World TB Day

TB primarily affects adults during their most productive years, greatly impacting the livelihood of families while also threatening already vulnerable economies in developing nations.

Annually, people from all walks of life globally commemorate World TB Day on March 24.

India retains the dubious distinction of being the TB capital of the world since 2008.

Moreover, World TB Day functions along with rallies were also observed across Kashmir Division by District TB control societies under the aegis of Directorate of Health Services Kashmir. The significant symptoms which may point towards a person having TB is continued cough for over three weeks, coughing up blood, chest pain, sudden weight loss, fatigue, fever, night sweats, chills and loss of appetite.

Any isoniazid (another first line anti TB drug) resistance was found to be 11.06% and 25.09% among new and previously treated TB patients, respectively.

However, the disease has been making a comeback in the recent years, especially among the Dalit and lesser-privileged communities of India. It's not possible to suspend treatment of TB during pregnancy, but at the same time, TB patients can't afford to get pregnant while undergoing treatment.

Earlier in around three years, TB care in the public health sector is seeing the improvement and not only it provides some major diagnostic facilities, but also in an expenditure of the new treatments, principally Bedaquiline, the newest anti-TB drug which introduced to cure the TB nearly four decades ago, worldwide, the doctors said.

World Health Organization says that "When it comes to the biggest worldwide killer that kills through a single infectious agent, Tuberculosis (TB) comes second only to HIV/AIDS".

The WHO said that over 95 per cent of TB deaths occur in low and middle-income countries.

In active TB, the germs are much active and multiply too quickly. At U.S. Mission India, the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Agency for International Development (USAID), and the National Institutes of Health have invested more than $150 million with in-country partners since 1998 in the fight to end TB in India by the Government of India's 2025 target.

Facilities for treating drug-resistant TB have also witnessed a decentralization over time - from six in 2016 to 14 this year.

According to the data available with India Today, at present, there are 318 patients identified with MDR TB, 29 with XDR TB and 7060 with ordinary TB. "End TB" and will be held in Nairobi's Embakasi estate. Government of India has been spending millions in providing free treatment the treatment of TB since decades. There are many out there in the society, who will not let others succeed, but people should trust their own abilities. This model was further supported by a special information system to track expenditures for all patients at TB hospitals in a timely, secure, and reliable manner.

Also read: Is Tuberculosis A Dangerous Disease?

Related Articles